Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 05, 2017

TAKEDA PHARMACEUTICAL COMPANY LTD. et al v. TORRENT PHARMACEUTICALS LTD. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 06, 2020

    Takeda Beats Rivals' Challenge To Diabetes Drug Patent

    Takeda Pharmaceuticals Ltd. defeated a bid by two generic-drug makers to invalidate a patent for its brand-name Type II diabetes treatments when a New Jersey federal judge said there was no proof the formula was too obvious to warrant protections.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login